Clinical Trials Browser

Interventional × Aclarubicin × Lymphoid × Clear all

NCT07541755 2026-04-21

PD1-VEN-CAG

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07535710 2026-04-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

Phase 1/2 Not yet recruiting

DermatologicLymphoid

Recurrence, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT07535762 2026-04-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic